Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Kompresija hrbtenjače
Authors:ID Matos, Erika (Author)
Files:.pdf PDF - Presentation file, download (62,56 KB)
MD5: CA29DCB925C1A103E6A20E35DD232E37
PID: 20.500.12556/dirros/e89fb135-1491-479d-85f9-529b700133d3
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Abstract:Kompresija hrbtenjače je zaplet rakave bolezni, ki redko ogroža bolnikovo življenje, če pa je ne odkrijemo, lahko že v nekaj urah vodi do nepopravljive okvare hrbtenjače s trajno paralizo. Do kompresije hrbtenjače največkrat pride pri bolnikih z zasevki v hrbtenici, redkeje je posledica neposrednega vraščanja mehkotkivne tumorske mase v hrbtenični kanal. Do tega zapleta najpogosteje pride pri bolnikih z rakom pljuč, dojke, prostate, ščitnice, ledvice in s plazmocitomom. Bolnik kot prve težave navaja bolečine v hrbtenici, temu se pridružijo nevrološki izpadi. Nivo kompresije hrbtenjače določimo z nevrološkim pregledom. Od diagnostičnih metod je na prvem mestu rentgensko slikanje, ki pa nam pokaže le skeletne nepravilnosti, zato je za opredelitev kompresije hrbtenjače nujna MRI. Pri grozeči kompresiji hrbtenjače moramo ukrepati takoj. Bolniku svetujemo mirovanje, predpišemo mu analgetike in glukokortikoide. Izbira zdravljenja je odvisna od narave bolezni, obsega prizadetosti hrbteničnega kanala in bolnikovega splošnega stanja. Obsega kirurško zdravljenje v kombinaciji z obsevanjem in sistemskim zdravljenjem ali pa le obsevanje skupaj s sistemskim zdravljenjem ali brez njega. V vsakem primeru je pri sumu, da gre za kompresijo hrbtenjače, pomembno, da zdravljenje začnemo čim prej.
Publication status:Published
Publication version:Version of Record
Year of publishing:2009
Number of pages:str. 43-44
Numbering:Letn. 13, št. 1
PID:20.500.12556/DiRROS-9136 New window
UDC:616-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-QVH7ZT37
COBISS.SI-ID:25709529 New window
Copyright:by Authors
Note:BSDOCID145259;
Publication date in DiRROS:31.08.2018
Views:4344
Downloads:696
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:Undetermined
Title:Spynal Cord Compession
Abstract:Spinal cord compression is a complication of cancer that is usually not immediately life-threatening, but can lead to significant morbidity in a different way. The mechanisms by which tumors can compress the spinal cord are hematogenous spread of tumor cells to the vertebra, or rarely, by direct extension of paraspinal tumors into the spine. Such compression is predominantly due to metastatic spread of the lung, breast, prostate, thyroid, kidney cancer or multiple myeloma. The most common presentation of spinal cord compression is back pain that is followed by neurological impairment. The level of compression should be determined by physical examination. A standard x-ray is generally ordered first, but it shows only bony lesions. However, MRI is the imaging technique of choice for suspected spinal cord compression. Spinal cord compression needs urgent treatment. Patient has to be prescribed analgetics and glucocorticoids and rest is advised. The choice of treatment depends on primary cancer type, degree of spinal cord damage and general performance status of the patient. Surgery in combination with radiotherapy and systemic therapy is treatment of choice in some cases, but radiotherapy alone or in combination with systemic therapy is sometimes an option. In any case, it is important to start the treatment as soon as possible.


Archive

niGradiv

Back